The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of endocrinology:
Can Thyroid Nodule Localization Predict Thyroid Cancer?Stefan Amisten, Senior Medical Writer, Touch Medical Media, UK Jeremy Betts, Account Director and Advisory Editor, Touch Medical Media, UK -Insights into a Recently Released Study Revealing Thyroid Nodule Location's Predictive Value for Malignancy, presented at AACE, Boston, US, 18 May 2018
Jeffrey S Elmendorf discusses the impact of cholesterol in type 2 diabetes and the latest findings from current studies.
Questions:
1. Why is cholesterol of interest for metabolic health and disease? (0:07)
2. Is cellular cholesterol toxicity and type 2 diabetes risk supported by clinical...
Professor Stumvoll discusses his "Meet the Expert" session focussing on two patients with partial lipodystrophy.
Speaker's disclosures: Speaker fees from Aegerion.
This video is intended for health care professionals.
Information for patients and carers can be found here
Product...
As well as our peer-reviewed journals, we also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.
Behind insulin resistance: debugging the endocrine system. How to tackle leptin deficiency in lipodystrophies.
Speaker's disclosures: Julia von Schnurbein received speaker’s fees from Aegerion,...
Jeffrey S Elmendorf discusses the impact of cholesterol in type 2 diabetes and the latest findings from current studies.
Questions:
1. Why is cholesterol of interest for metabolic health and...
Professor Stumvoll discusses his "Meet the Expert" session focussing on two patients with partial lipodystrophy.
Speaker's disclosures: Speaker fees from Aegerion.
This video is intended...
Julia von Schnurbein discusses the latest advances in Myalepta and patients with lipodystrophies in Europe.
Questions:
1. How can diabetologists recognise patients with lipodystrophies and...
Professor Oral summarises her key take home messages from her Aegerion-sponsored satellite symposium.
Speaker's disclosures: Professor Oral is a consultant to Aegerion Pharmaceuticals with...
Dr Giovanni Ceccarini discusses the key take-home messages from his Aegerion-sponsored Meet the Experts session at EASD 2018, where he focused on studies and therapeutics for patients with...
US Endocrinology. 2018;14(2):77–9 DOI: https://doi.org/10.17925/USE.2018.14.2.77
US Endocrinology. 2018;14(2):67–72 DOI: https://doi.org/10.17925/USE.2018.14.2.67
US Endocrinology. 2018;14(2):59–61 DOI: https://doi.org/10.17925/USE.2018.14.2.59
US Endocrinology. 2018;14(2):87–92 DOI: https://doi.org/10.17925/USE.2018.14.2.87
US Endocrinology, 2018;14(2):65–6 DOI: https://doi.org/10.17925/USE.2018.14.2.65
Behind insulin resistance: debugging the endocrine system. How to tackle leptin deficiency in lipodystrophies. Speaker's disclosures: Julia von Schnurbein received speaker’s fees from Aegerion,...
Julia von Schnurbein discusses the latest advances in Myalepta and patients with lipodystrophies in Europe. Questions: 1. How can diabetologists recognise patients with lipodystrophies and...
Professor Oral summarises her key take home messages from her Aegerion-sponsored satellite symposium. Speaker's disclosures: Professor Oral is a consultant to Aegerion Pharmaceuticals with...
Dr Giovanni Ceccarini discusses the key take-home messages from his Aegerion-sponsored Meet the Experts session at EASD 2018, where he focused on studies and therapeutics for patients with...
